Levothyroxine therapy and osteoporosis. An end to the controversy?
Wartofsky
L
L
Department of Medicine, Washington Hospital Center, Washington, DC 20010-2975, USA.
D015519:Bone Density / Q000187:drug effects; D005260:Female; D006801:Humans; D010024:Osteoporosis / Q000139:chemically induced* / Q000503:physiopathology; D015663:Osteoporosis, Postmenopausal / Q000139:chemically induced; D013974:Thyroxine / Q000009:adverse effects*
D013974:Thyroxine